Halawani A, Mobarki A, Arjan A, Saboor M, Hamali H, Dobie G
Int J Gen Med. 2022; 15:4093-4100.
PMID: 35450032
PMC: 9017690.
DOI: 10.2147/IJGM.S360320.
Migdady Y, Pang Y, Kalsi S, Childs R, Arai S
Blood Adv. 2021; 6(8):2707-2721.
PMID: 34972204
PMC: 9043947.
DOI: 10.1182/bloodadvances.2021006279.
Bougie D, Sutton J, Aster R
Blood Adv. 2020; 4(2):287-295.
PMID: 31968077
PMC: 6988389.
DOI: 10.1182/bloodadvances.2019000661.
Al-Riyami A, Daar S
Sultan Qaboos Univ Med J. 2018; 18(1):e3-e12.
PMID: 29666675
PMC: 5892809.
DOI: 10.18295/squmj.2018.18.01.002.
Singhal D, Kutyna M, Chhetri R, Wee L, Hague S, Nath L
Haematologica. 2017; 102(12):2021-2029.
PMID: 28983058
PMC: 5709101.
DOI: 10.3324/haematol.2017.175752.
An unexpected development after surgery-post-transfusion purpura!.
Falk G, Winans C, Bowens K, Bougie D, Curtis B, Aster R
Am J Hematol. 2016; 91(8):848-51.
PMID: 27159228
PMC: 5045246.
DOI: 10.1002/ajh.24414.
'Chameleonic' Serological Findings Leading to Life-Threatening Hemolytic Transfusion Reactions.
Sumnig A, Mayer B, Kiefel V, Greinacher A, Salama A
Transfus Med Hemother. 2015; 42(5):340-3.
PMID: 26696804
PMC: 4678317.
DOI: 10.1159/000437198.
Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.
Elayeb R, Tamagne M, Bierling P, Noizat-Pirenne F, Vingert B
Haematologica. 2015; 101(2):209-18.
PMID: 26430173
PMC: 4938341.
DOI: 10.3324/haematol.2015.134171.
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
Telen M, Afenyi-Annan A, Garrett M, Combs M, Orringer E, Ashley-Koch A
Transfusion. 2014; 55(6 Pt 2):1378-87.
PMID: 25444611
PMC: 4451450.
DOI: 10.1111/trf.12940.
Detection of alloimmunization to ensure safer transfusion practice.
Sood R, Makroo R, Riana V, Rosamma N
Asian J Transfus Sci. 2013; 7(2):135-9.
PMID: 24014944
PMC: 3757774.
DOI: 10.4103/0973-6247.115577.
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.
Yazdanbakhsh K, Ware R, Noizat-Pirenne F
Blood. 2012; 120(3):528-37.
PMID: 22563085
PMC: 3401213.
DOI: 10.1182/blood-2011-11-327361.
Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study.
Okutsu M, Ohto H, Yasuda H, Kawabata K, Ono S, Saito S
Blood Transfus. 2011; 9(3):311-9.
PMID: 21251459
PMC: 3136600.
DOI: 10.2450/2010.0057-10.
Development of warm auto- and allo-antibodies in a 3-year old boy with sickle cell haemoglobinopathy following his first transfusion of a single unit of red blood cells.
McNerney M, Baron B, Volchenboum S, Papari M, Keith M, Williams K
Blood Transfus. 2010; 8(2):126-8.
PMID: 20383307
PMC: 2851217.
DOI: 10.2450/2009.0105-09.
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
McPherson M, Anderson A, Castillejo M, Hillyer C, Bray R, Gebel H
Pediatr Blood Cancer. 2009; 54(4):552-8.
PMID: 19890898
PMC: 3722881.
DOI: 10.1002/pbc.22327.
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
Valent P, Lechner K
Wien Klin Wochenschr. 2008; 120(5-6):136-51.
PMID: 18365153
DOI: 10.1007/s00508-008-0945-1.
